- World rank, all time
- #21,278 of 42,892
- Rank in United States
- #4,599 of 8,685
- Research works
- 152 ▲ 188% vs 2013–17
- Citations
- 3.3k 21.8 per fractional work
- Top-10% rate
- 18.3% record average 16.5%
- Open access
- 47% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 16.7×. Every wedge is a field page.
- Neuroscience 16.7×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Pharmacology, Toxicology and Pharmaceutics 2.7×
- Psychology 2.1×
- Immunology and Microbiology 2.0×
- Medicine 1.9×
- Health Professions 1.1×
- Mathematics 1.0×
- Decision Sciences 0.8×
- Nursing 0.5×
- Economics, Econometrics and Finance 0.4×
- Chemistry 0.3×
- Computer Science 0.2×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.0×
- Engineering 0.0×
Who are the top researchers at Sage Therapeutics (United States)?
Ranked on the composite score, James Doherty, Shane Raines and Stephen Kanes lead among researchers whose main affiliation is Sage Therapeutics (United States).
- 1 James Doherty United States · #329,261 worldwide 110 citations · 23 works
- 2 Shane Raines United States · #582,087 worldwide 55 citations · 15 works
- 3 Stephen Kanes United States · #583,525 worldwide 60 citations · 20 works
- 4 Michael C. Quirk United States · #913,739 worldwide 79 citations · 15 works
- 5 Robert Lasser United States · #962,266 worldwide 41 citations · 23 works
- 6 Francesco G. Salituro United States · #1,334,193 worldwide 22 citations · 16 works
Which keywords describe research at Sage Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Mitochondrial Dysfunction, Protein Aggregation, Huntington's Disease, Polyglutamine, Depression, Neurological Disorders, Synaptic Plasticity and Treatment-Resistant Depression.
- Psychological Interventions
- Health Outcomes
- Child Development
- Schizophrenia
- Neuroimaging
- Cell Signaling
- Subthalamic Nucleus
- Dendritic Spines
- Meta-Analysis
- Pharmacology
- Diagnostic Criteria
- Basal Ganglia
- Neurobiology
- Epilepsy
- Cognitive Impairment
- Oxidative Stress
- Treatment-Resistant Depression
- Neurological Disorders
- Protein Aggregation
- Huntington's Disease
- Mitochondrial Dysfunction
- Polyglutamine
- Depression
- Synaptic Plasticity
- Parkinson's Disease
- Alzheimer's Disease
- Neurodegeneration
- NMDA Receptor
- Antidepressant
- Ketamine
- Metabolism
- Biomarkers
- Deep Brain Stimulation
- Dopaminergic Neurons
- a-Synuclein
- GABAergic
- Neurotransmission
- Toxicology
- Crystal Structure
- Maternal Mental Health
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Mitochondrial Dysfunction8▲ 59×3 topics
- Huntington's Disease6▲ 448×1 topic
- Polyglutamine6▲ 448×1 topic
- Protein Aggregation6▲ 256×2 topics
- Depression5▲ 13×12 topics
- Neurological Disorders5▲ 17×10 topics
- Synaptic Plasticity4▲ 35×3 topics
- Treatment-Resistant Depression4▲ 119×2 topics
- Parkinson's Disease3▲ 28×4 topics
- Oxidative Stress3▲ 3.9×9 topics
- Alzheimer's Disease3▲ 22×5 topics
- Cognitive Impairment3▲ 24×7 topics
- Neurodegeneration2▲ 18×4 topics
- Epilepsy2▲ 41×3 topics
- NMDA Receptor2▲ 113×2 topics
- Neurobiology2▲ 17×7 topics
- Antidepressant2▲ 176×1 topic
- Basal Ganglia2▲ 77×2 topics
- Ketamine2▲ 176×1 topic
- Diagnostic Criteria2▲ 18×4 topics
- Metabolism2▲ 7.7×6 topics
- Pharmacology2▲ 15×2 topics
- Biomarkers2▲ 5.1×3 topics
- Meta-Analysis2▲ 6.0×7 topics
- Deep Brain Stimulation2▲ 50×1 topic
- Dendritic Spines2▲ 43×2 topics
- Dopaminergic Neurons2▲ 52×1 topic
- Subthalamic Nucleus2▲ 86×1 topic
- a-Synuclein2▲ 64×1 topic
- Cell Signaling2▲ 20×5 topics
- GABAergic2▲ 63×1 topic
- Neuroimaging2▲ 12×3 topics
- Neurotransmission2▲ 63×1 topic
- Schizophrenia2▲ 30×4 topics
- Toxicology2▲ 18×2 topics
- Child Development1▲ 6.9×3 topics
- Crystal Structure1▲ 20×2 topics
- Health Outcomes1▲ 10.0×3 topics
- Maternal Mental Health1▲ 52×1 topic
- Psychological Interventions1▲ 21×2 topics
Which research topics does Sage Therapeutics (United States) publish most on?
By volume in 2022–2025: Genetic Neurodegenerative Diseases, Treatment of Major Depression, Parkinson's Disease Mechanisms and Treatments and Neurological disorders and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 6 works
- 2 Treatment of Major Depression Pharmacology 2 works
- 3 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
- 4 Neurological disorders and treatments Neurology 2 works
- 5 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 2 works
- 6 Maternal Mental Health During Pregnancy and Postpartum Public Health, Environmental and Occupational Health 1 works
- 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 1 works
- 8 Cholinesterase and Neurodegenerative Diseases Pharmacology 1 works
- 9 Receptor Mechanisms and Signaling Molecular Biology 1 works
- 10 Cholesterol and Lipid Metabolism Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sage Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 188% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.